Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
importin 8 | 0.722 | 0.346 | 0.23 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
regulatory factor X7 | 0.780 | 0.385 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
T-box transcription factor 10 | 2.1E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||||
|
jumonji domain containing 1C | 0.517 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
mono-ADP ribosylhydrolase 1 | 0.716 | 0.462 | 0.57 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
MN1 proto-oncogene, transcriptional regulator | 0.682 | 0.385 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
CD79b molecule | 0.576 | 0.577 | 0.92 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
EFR3 homolog B | 0.890 | 0.231 | 2.4E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
cytoplasmic polyadenylation element binding protein 3 | 0.805 | 0.192 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
leucine rich repeat containing 36 | 7.7E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||||
|
fibronectin leucine rich transmembrane protein 1 | 0.780 | 0.231 | 0.36 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
protein phosphatase 2 regulatory subunit B''alpha | 0.805 | 0.231 | 0.62 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
prolyl 4-hydroxylase, transmembrane | 0.666 | 0.500 | 3.9E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
nuclear receptor interacting protein 3 | 2.2E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||||
|
RAB26, member RAS oncogene family | 0.861 | 0.077 | 1.7E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
AT-rich interaction domain 5B | 0.638 | 0.500 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
RNA binding motif protein 6 | 0.722 | 0.385 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
ankyrin repeat and sterile alpha motif domain containing 1B | 0.686 | 0.423 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
corticotropin releasing hormone receptor 1 | 0.517 | 0.769 | 3.8E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
EHMT2 and SLC44A4 antisense RNA 1 | 0.780 | 0.462 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 343 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
cordon-bleu WH2 repeat protein like 1 | 0.792 | 0.346 | 4.7E-02 |
|
phenotype | 0.100 | None | 1.000 | 8 | 7 | 2010 | 2019 | ||||||||
|
R-spondin 3 | 0.653 | 0.423 | 8.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 7 | 5 | 2010 | 2019 | ||||||||
|
ADAMTS9 antisense RNA 2 | 0.656 | 0.462 |
|
phenotype | 0.100 | None | 1.000 | 6 | 6 | 2010 | 2019 |